Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [HEALTH]
2 clusters · 8 sources · 3 days · First seen · Last updated
University of Cambridge mRNA heart therapy research
Overview
Researchers at the University of Cambridge have developed an experimental mRNA therapy designed to stimulate the regeneration of heart muscle cells. The treatment aims to address heart failure by reactivating the ability of cardiac cells to divide and repair damaged tissue, a process that typically ceases after childhood.
In studies published in Nature Cardiovascular Research, the therapy was tested on mice following a myocardial infarction. By temporarily activating two specific proteins, Myc and Cyclin T1, the treatment resulted in a nearly 10% increase in the amount of blood pumped per heartbeat compared to a control group. These improvements were sustained through 12 weeks of observation.
While the therapy remains in the experimental stage and has not yet been tested in humans, researchers suggest it could potentially improve the quality of life for millions. Future steps involve trials in larger animal models, supported by funding from the British Heart Foundation.
Entities
University of Cambridge · Nature Cardiovascular Research · Gurdon Institute · Catherine Wilson · British Heart Foundation
Timeline
-
[HEALTH] 2 sourcesUniversity of Cambridge researchers develop mRNA therapy to repair heart tissue
University of Cambridge scientists developed an mRNA therapy that reactivates heart muscle cells to repair damage after a heart attack, improving pumping efficiency by 10% in mouse studies.
-
[HEALTH] 6 sourcesUniversity of Cambridge researchers develop mRNA therapy to repair heart muscle
University of Cambridge scientists have developed an mRNA therapy that enables heart muscle cells to divide and repair damage, showing a 10% increase in blood pumping efficiency in mouse studies.
Sources
actualidad-rt.com · extra.ie · kirkinews.gr · lomazoma.com · medicaldialogues.in · minuto30.com · news-medical.net · zougla.gr